Sort
17,288 grants matching “multiple sclerosis”
Oncostatin M-induced VEGF in human breast cancer is HIF1a-mediated
$211,500Cheryl Lynn Jorcyk · Boise State University · R15 · FY2009 · CA
NINDS Research Education Programs for Residents and Fellows in Neurology and Neur
$211,496Argye E. Hillis · Johns Hopkins University · R25 · FY2012 · NS
Development of a novel model to study the effects of LINE-1 retrotransposons in disease and normal physiology using nanobodies
$211,485Pamela Cook · Mercer University Macon · R21 · FY2025 · GM
Alcohol abuse and blood-brain barrier dysfunction: Underlying mechanisms
$211,313James Haorah · University Of Nebraska Medical Center · R21 · FY2009 · AA
Genetically modified HSC-HPC for management of aggressive demyelinating diseases
$211,250Jack L Strominger · Harvard University · R21 · FY2015 · AI
Role of telomerase in myelination and remyelination
$211,250Neeta S Roy · Weill Medical Coll Of Cornell Univ · R21 · FY2010 · NS
Novel BEAM and R26-BEACON recombinase-based systems for mosaic analysis of gene function
$211,250Jeffrey D Macklis · Harvard University · R21 · FY2019 · NS
Quantifying Demyelination and Axonal Loss with Diffusion MRI
$211,250Els Fieremans · New York University School Of Medicine · R21 · FY2012 · NS
Role of telomerase in myelination and remyelination
$211,250Neeta S Roy · Weill Medical Coll Of Cornell Univ · R21 · FY2009 · NS
Monoallelic Expression and Inheritance of CNS Disorders
$211,250Judith Singer-Sam · Beckman Research Institute/City Of Hope · R21 · FY2006 · MH
PATHOGENIC MECHANISMS OF TMEV INDUCED DEMYELINATION
$211,082Northwestern University · R01 · FY2000 · NS
PAK1 Activation Reduces Muscular Dystrophy-Mediated Fibrosis
$211,068Ahlke Heydemann · University Of Illinois At Chicago · R21 · FY2016 · AR
UManage Projects Core
$211,036Annette B Wysocki · University Of Massachusetts Amherst · P20 · FY2018 · NR
DNA-Based Biomarkers for Multiple Sclerosis
$210,995Victor V Levenson · Northwestern University At Chicago · R21 · FY2007 · NS
Cellular and molecular mechanisms underlying neuronal activity-controlled regeneration specificity
$210,950Yang Xiang · Univ Of Massachusetts Med Sch Worcester · R21 · FY2019 · NS
Pathobiological Studies of Neurodegenerative Diseases
$210,940Huaibin Cai · National Institute On Aging · Z01 · FY2008 · AG
Development of Validation of Phage-Displayed Random Peptide Libraries Technologies for Rapid Isolation and Characterization of Extracellular Vesicles from Patients with Brain Tumors
$210,752Michael W. Graner · University Of Colorado Denver · R21 · FY2019 · MH
Regulation of Neuroinflammation by Meningeal Lymphatics
$210,750Zsuzsanna Fabry · University Of Wisconsin-Madison · R01 · FY2024 · NS
CALPAIN IN THE PATHOPHYSIOLOGY OF DEMYELINATING DISEASE
$210,721Medical University Of South Carolina · R01 · FY2003 · NS
EVALUATING THE METABOLIC CHANGES ASSOCIATED WITH EXERCISE IN MULTIPLE SCLEROSIS
$210,712The Johns Hopkins University · · FY2017 · Department of the Army
Regulation of mitochondrial dehdyrogenases and neuronal NADH levels via interaction of NIPSNAP1 and APP intracellular domain
$210,675Ramin Homayouni · University Of Memphis · R21 · FY2017 · AG
CNS Myelination Co-Culture Microsystem for Axon-Gila Signaling
$210,603Arum Han · Texas Engineering Experiment Station · R21 · FY2009 · MH
A novel cell-based high-throughput assay for ALS
$210,394Serge E Przedborski · Columbia University Health Sciences · R21 · FY2009 · NS
Experimental Therapeutics in Neurological Disease
$210,321Robert C Griggs · University Of Rochester · T32 · FY2009 · NS
Peptide therapy for alcohol-induced CNS injury
$210,306Mohammed Abdul Muneer · Hackensack University Medical Center · R21 · FY2024 · AA